+479.4%
NBIS vs THC
+75.4%
+404.0%
-59.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -9.9% | -0.3% | -9.6% | -9.9% |
| 7D | -10.5% | +1.0% | -11.5% | -10.5% |
| 30D | -37.7% | +5.3% | -43.0% | -38.1% |
| 3M | -54.6% | +7.1% | -61.7% | -55.1% |
| 6M | -44.1% | +46.0% | -90.1% | -48.7% |
| YTD | +38.4% | +43.9% | -5.5% | +26.0% |
| 1Y | +30.7% | +45.4% | -14.7% | +18.6% |
| All | +479.4% | +75.4% | +404.0% | +347.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling